Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,954.00
(
0.00%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.48
(
-1.27%
)
Bitcoin
74,726.69
(
1.17%
)
News Focus
News Focus
Post# of 405179
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

scottsmith

Send PM Follow Ignore
Followers 61
Posts 11632
Boards Moderated 0
Alias Born 01/04/2015

scottsmith

Re: groton68 post# 237879

Monday, 08/20/2018 4:47:26 PM

Monday, August 20, 2018 4:47:26 PM

Post# of 405179
Nope. Read the damn article.

“GC4419 has completed phase 1 and 2 trials and is poised to enter phase 3 this year. If approved, it could be used to ward off SOM and its side effects not just in patients with head and neck cancers, but in those with other types of cancer.”

All my comments are Rated As Pro.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote